Cohort monitoring of Adverse Events of Special Interest and COVID-19 diagnoses prior to and after COVID-19 vaccination (ECVM)First published 01/04/2021 Last updated 01/07/2024 EU PAS number: EUPAS40404StudyFinalised
University Medical Center Utrecht (UMCU)Netherlands First published: 24/11/2021Last updated 22/02/2024 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityENCePP partner
Division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht UniversityNetherlands First published: 01/03/2010Last updated 23/05/2024 InstitutionEducational InstitutionENCePP partner
University Medical Center Utrecht (UMCU)Netherlands First published: 24/11/2021Last updated 22/02/2024 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityENCePP partner
The PHARMO Institute for Drug Outcomes Research (PHARMO Institute)Netherlands First published: 07/01/2022Last updated 24/07/2024 InstitutionLaboratory/Research/Testing facilityENCePP partner
Agencia Española de Medicamentos y Productos Sanitarios (Spanish Agency for Medicines and Medical Devices, AEMPS)Spain First published: 01/02/2024Last updated 04/09/2024 InstitutionEU Institution/Body/AgencyNot-for-profitRegulatory AuthorityENCePP partner
Vaccine monitoring Collaboration for Europe (VAC4EU)BelgiumDenmarkFinlandFranceGermanyItalyNetherlandsNorwaySpainUnited Kingdom First published: 22/09/2020Last updated 22/09/2020 NetworkENCePP partner
EU Pharmacoepidemiology and Pharmacovigilance (PE&PV) Research NetworkNetherlands First published: 01/02/2024Last updated 26/11/2024 Network